PT - JOURNAL ARTICLE AU - Chen, Simiao AU - Prettner, Klaus AU - Kuhn, Michael AU - Geldsetzer, Pascal AU - Wang, Chen AU - Bärnighausen, Till AU - Bloom, David E. TI - COVID-19 and climate: global evidence from 117 countries AID - 10.1101/2020.06.04.20121863 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.04.20121863 4099 - http://medrxiv.org/content/early/2020/06/05/2020.06.04.20121863.short 4100 - http://medrxiv.org/content/early/2020/06/05/2020.06.04.20121863.full AB - Visual inspection of world maps shows that coronavirus disease 2019 (COVID-19) is less prevalent in countries closer to the equator, where heat and humidity tend to be higher. Scientists disagree how to interpret this observation because the relationship between COVID-19 and climatic conditions may be confounded by many factors. We regress confirmed COVID-19 cases per million inhabitants in a country against the country’s distance from the equator, controlling key confounding factors: air travel, distance to Wuhan, testing intensity, cell phone usage, vehicle concentration, urbanization, and income. A one-degree increase in absolute latitude is associated with a 2.6% increase in cases per million inhabitants (p value < 0.001). The Northern hemisphere may see a decline in new COVID-19 cases during summer and a resurgence during winter.One Sentence Summary An increase in absolute latitude by one degree is associated with a 2.6% increase in COVID-19 cases per million inhabitants after controlling for several important factors.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPG was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number KL2TR003143. DEB was supported by the National Institute on Aging of the National Institutes of Health under Award Number P30AG024409 and by the Value of Vaccination Research Network (VoVRN) through a grant from the Bill & Melinda Gates Foundation (BMGF Grant OPP1158136), United States. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily reflect the views of the NIH, the VoVRN or the BMGF.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study used only publicly available, deidentified data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available in the main text or the supplementary materials.